VEGFA and prostate carcinoma: In addition, EGCG inhibited angiogenesis and metastasis through repressing the expression of vascular endothelial growth factor (VEGF), and matrix metalloproteinases (MMP)-2 and MMP-9 in prostate cancer [18].